Search Within

Subhiksha Nandakumar

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (22)
Groups
  1. Sloan Kettering Institute Postdocs (47)
  2. Department of Medicine (42)
  3. Solid Tumor Oncology Division (42)
  4. Genitourinary Oncology Service (36)
  5. GSK Faculty (31)
  6. Human Oncology and Pathogenesis Program (29)

More Groups

People
  1. Philip Kantoff (26)
  2. Nikolaus Schultz (21)
  3. Ying Mazzu (21)
  4. Goutam Chakraborty (20)
  5. Yuki Yoshikawa (16)
  6. David Solit (14)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (3)
  4. 2022 (12)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Cancer Research (11)
  2. Journal of Clinical Oncology (8)
  3. Clinical Cancer Research (7)
  4. Molecular Oncology (4)
  5. Neuro-Oncology (4)
  6. Acta Neuropathologica Communications (1)

More Publications

Publishers
  1. American Association for Cancer Research (20)
  2. American Society of Clinical Oncology (8)
  3. FEBS Press (4)
  4. Oxford University Press (4)
  5. Nature Publishing Group (3)
  6. BioMed Central Ltd. (1)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Wibmer, A. G.; Haywood, S.; Weg, E. S.; Barnett, E. S.; Kim, C. J.; Carbone, E. A.; Vasselman, S. E.; Nguyen, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer
    Meeting Abstract

    Yoshikawa, Y.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Chakraborty, G.; Jehane, L. E.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; Stopsack, K. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
    Meeting Abstract

    Chakraborty, G.; Ghosh, A.; Nandakumar, S.; Armenia, J.; Mazzu, Y. Z.; Atiq, M. O.; Lee, G. S. M.; Mucci, L. A.; Merghoub, T.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Checkpoint kinase inhibition in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Targeting checkpoint kinases in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Jehane, L. E.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR193b silencing activates master drivers of aggressive prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Chakraborty, G.; Yoshikawa, Y.; Nandakuma, S.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save